11:10 AM EST, 12/13/2024 (MT Newswires) -- European equities traded in the US as American depositary receipts were lower late Friday morning, declining 0.25% to 1,337.43 on the S&P Europe Select ADR Index, which is down 1.5% for the week.

From continental Europe, the gainers were led by financial services companies ING (ING) and Banco Bilbao Vizcaya Argentaria ( BBVA ) , which rose 1.3% and 0.8% respectively. They were followed by financial services company Banco Santander (SAN) and telecommunications company Ericsson (ERIC), which were up 0.7% and 0.5% respectively.

The decliners from continental Europe were led by biopharmaceutical company DBV Technologies ( DBVT ) and biotech firm Evaxion Biotech ( EVAX ) , which fell 11.6% and 9.1% respectively. They were followed by furniture maker Natuzzi (NTZ) and 3D printer company Materialise (MTLS), which lost 11.4% and 5.2% respectively.

From the UK and Ireland, the gainers were led by biopharmaceutical company Akari Therapeutics ( AKTX ) and alcoholic beverage company Diageo ( DEO ) , which increased 4.2% and 1.8% respectively. They were followed by biopharmaceutical company Verona Pharma ( VRNA ) and biopharmaceutical company NuCana ( NCNA ) , which advanced 0.9% and 0.7% respectively.

The decliners from the UK and Ireland were led by biopharmaceutical companies Bicycle Therapeutics ( BCYC ) and Adaptimmune Therapeutics ( ADAP ) , which tumbled 33.1% and 11.5% respectively. They were followed by biopharmaceutical companies Biodexa Pharmaceuticals ( BDRX ) and TC Biopharm ( TCBP ) , which dropped 4.8% and 3.3% respectively.